SPC Logo

Pabrinex Intravenous High Potency Injection

Last Updated on eMC 27-May-2015 View document  | Archimedes Pharma UK Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27-May-2015 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 28-Jul-2014 and displayed until 27-May-2015

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 5 - how to store
  • Change to section 6 - date of revision

Updated on 18-Apr-2013 and displayed until 28-Jul-2014

Reasons for adding or updating:

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 11-Jan-2013 and displayed until 18-Apr-2013

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 03-Nov-2010 and displayed until 11-Jan-2013

Reasons for adding or updating:

  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to dosage and administration
  • Change due to user-testing of patient information

Updated on 12-May-2010 and displayed until 03-Nov-2010

Reasons for adding or updating:

  • Change due to user-testing of patient information

Updated on 03-Mar-2009 and displayed until 12-May-2010

Reasons for adding or updating:

  • Change to date of revision

Updated on 15-Sep-2008 and displayed until 03-Mar-2009

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 10-Mar-2008 and displayed until 15-Sep-2008

Reasons for adding or updating:

  • Change of licence holder

Updated on 21-Jun-2006 and displayed until 10-Mar-2008

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Archimedes Pharma UK Ltd

Company image
Address

Galabank Business Park, Galashiels, TD1 1QH, UK

Fax

+44 (0)1896 664 001

Medical Information e-mail
Telephone

+44 (0)1896 664 000

Medical Information Direct Line

+44 (0)1896 664 000

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

ascorbic acid, glucose, anhydrous, nicotinamide, pyridoxine, riboflavin, thiamine

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue